Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia

Cell Cycle. 2012 Dec 1;11(23):4300-1. doi: 10.4161/cc.22808. Epub 2012 Nov 16.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / toxicity*
  • Cell Survival / drug effects*
  • Eukaryotic Initiation Factor-2 / metabolism*
  • Fusion Proteins, bcr-abl / metabolism*
  • Humans
  • Piperazines / toxicity*
  • Pyrimidines / toxicity*
  • eIF-2 Kinase / metabolism*

Substances

  • Antineoplastic Agents
  • Eukaryotic Initiation Factor-2
  • Piperazines
  • Pyrimidines
  • Fusion Proteins, bcr-abl
  • eIF-2 Kinase